GlassScriptPhysician profile
Jonathan Grant Haymore
NPI 1811191372
$2,682.86
in general payments reported to CMS, 2019-2025
7 companies · $344 in 2025
The $344 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.71 · 2021: $15.90 · 2022: $84.17 · 2023: $19.20 · 2024: $2,193 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Charitable Contribution: $1,012 · Travel and Lodging: $945 · Food and Beverage: $571 · Honoraria: $27.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Charitable Contribution | $1,012.34 |
| Travel and Lodging | $945.26 |
| Food and Beverage | $570.70 |
| Honoraria | $27.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,555.24 | 2019-2025 | Clareon, Centurion, Unity |
| Microsurgical Technology, INC. | $1,012.34 | 2024 | |
| Abbvie INC. | $31.01 | 2025 | |
| Rxsight INC | $27.78 | 2025 | Light Adjustable Lens (Lal), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Allergan, INC. | $21.45 | 2022 | |
| Bausch & Lomb Americas INC. | $20.67 | 2024 | Vyzulta |
| Rayner Intraocular Lenses Limited | $14.37 | 2025 | Rayone Spheric, Rayner Cataract Set 1, Rayone Emv |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Haymore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.